Related Experiment Video
Updated: May 21, 2026

14:14
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
[Prosthetic valve re-replacement one year after the surgery using a mosaic bioprosthesis]
Uhito Yuasa1, Shuhei Kogure, Naoki Yamamoto
1Department of Cardiovascular and Thoracic Surgery, Yamada Red Cross Hospital, Ise, Japan.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|June 1, 2012
Summary
A bioprosthetic aortic valve failed due to stent distortion and leaflet tears, likely caused by asymmetric septal hypertrophy (ASH). This led to recurrent syncope and necessitated valve re-replacement.
Area of Science:
- Cardiovascular Surgery
- Biomedical Engineering
- Cardiology
Background:
- Aortic valve stenosis can necessitate aortic valve replacement (AVR). Bioprosthetic valves are commonly used but can be subject to structural valve deterioration.
- Asymmetric septal hypertrophy (ASH) is a condition affecting the ventricular septum, potentially impacting cardiac function and hemodynamics.
Observation:
- A patient experienced recurrent syncope one year after AVR with a Mosaic bioprosthetic valve.
- Echocardiography revealed ASH, left ventricular outflow tract turbulence, and increased pressure gradient, indicating prosthetic valve dysfunction.
Findings:
- Surgical re-exploration identified tears on two coronary cusps of the bioprosthetic valve and subvalvular pannus formation.
- Analysis of the explanted valve showed distortion of the valvular stent, hypothesized to cause leaflet tears through contact.
- Pannus formation was attributed to turbulence induced by ASH and stent distortion.
Implications:
- Stent distortion in bioprosthetic aortic valves, potentially exacerbated by ASH, can lead to leaflet tears and valve failure.
- Pannus formation may be a consequence of altered hemodynamics secondary to ASH and valve stent distortion.
- These findings highlight the importance of considering ventricular septal morphology in the long-term performance of bioprosthetic aortic valves.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.

